U.S. markets open in 7 hours 29 minutes

Ultragenyx Pharmaceutical Inc. (RARE)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
114.53-1.18 (-1.02%)
At close: 4:00PM EDT
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2021)Next Qtr. (Sep 2021)Current Year (2021)Next Year (2022)
No. of Analysts13131315
Avg. Estimate-1.25-1.36-6.08-5.21
Low Estimate-1.8-2.12-8.16-7.75
High Estimate-0.82-0.88-3.42-2.99
Year Ago EPS0.41-1.13-3.07-6.08
Revenue EstimateCurrent Qtr. (Jun 2021)Next Qtr. (Sep 2021)Current Year (2021)Next Year (2022)
No. of Analysts10101314
Avg. Estimate84.31M79.78M334.88M405.9M
Low Estimate74M74M216M324.3M
High Estimate91.7M87.8M372.02M504.25M
Year Ago Sales61.71M81.47M271.03M334.88M
Sales Growth (year/est)36.60%-2.10%23.60%21.20%
Earnings History6/29/20209/29/202012/30/20203/30/2021
EPS Est.-1.54-1.26-1.15-1.24
EPS Actual0.41-1.13-0.37-2.03
Difference1.950.130.78-0.79
Surprise %126.60%10.30%67.80%-63.70%
EPS TrendCurrent Qtr. (Jun 2021)Next Qtr. (Sep 2021)Current Year (2021)Next Year (2022)
Current Estimate-1.25-1.36-6.08-5.21
7 Days Ago-1.3-1.33-5.26-4.53
30 Days Ago-1.26-1.27-5-4.24
60 Days Ago-1.29-1.3-5.12-4.29
90 Days Ago-1.15-1.12-4.09-3.1
EPS RevisionsCurrent Qtr. (Jun 2021)Next Qtr. (Sep 2021)Current Year (2021)Next Year (2022)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 Days6511
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesRAREIndustrySector(s)S&P 500
Current Qtr.-404.90%N/AN/AN/A
Next Qtr.-20.40%N/AN/AN/A
Current Year-98.00%N/AN/AN/A
Next Year14.30%N/AN/AN/A
Next 5 Years (per annum)17.20%N/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A